Dr. Yanzhi Song has more than a decade of clinical experience in hematopoietic stem cell transplantation (HSCT), with a dedicated focus on standardized transplantation procedures, strategic transplant planning, and comprehensive peri-transplant management. Throughout his clinical practice, he has managed a large number of transplant patients, gaining extensive experience across all stages of the transplantation process. He is highly proficient in identifying and managing transplant-related complications—including infections, graft-versus-host disease (GVHD), relapse, and hemorrhagic cystitis—and is able to make precise, systematic clinical decisions in complex and high-risk situations.
In academic and research work, Dr. Song has long been engaged in clinical studies related to HSCT and evidence-based medical practice in this field. As a corresponding author, he has published multiple SCI-indexed papers and has been invited to deliver oral presentations or poster discussions at international hematology conferences, demonstrating strong research capability and an international academic presence.
